Serotonin Syndrome Latest Advances

Find the Latest Research About Serotonin Syndrome

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2160 publications

Uveal Effusion and Exudative Macular Detachment Secondary to SSRI and Dexamphetamine Overdose.

Uveal Effusion and Exudative Macular Detachment Secondary to SSRI and Dexamphetamine Overdose.

Journal: Retinal cases & brief reports
Published: April 07, 2026

Serotonin syndrome presenting as severe reversible cerebral vasoconstriction syndrome.

Serotonin syndrome presenting as severe reversible cerebral vasoconstriction syndrome.

Journal: Practical neurology
Published: February 05, 2026

Severe 3,4-Methylenedioxymethamphetamine (MDMA)-Associated Rhabdomyolysis in Crohn's Disease: Direct Toxicity and Inflammatory Susceptibility in the Absence of Hyperthermia.

Severe 3,4-Methylenedioxymethamphetamine (MDMA)-Associated Rhabdomyolysis in Crohn's Disease: Direct Toxicity and Inflammatory Susceptibility in the Absence of Hyperthermia.

Journal: Cureus
Published: January 14, 2026

Cocaine-Induced Rhabdomyolysis With Acute Kidney Injury in the Absence of Serotonin Syndrome: A Case Report.

Cocaine-Induced Rhabdomyolysis With Acute Kidney Injury in the Absence of Serotonin Syndrome: A Case Report.

Journal: Cureus
Published: January 08, 2026

Cross-national differences in methylphenidate utilization in primarily adult psychiatric inpatients.

Cross-national differences in methylphenidate utilization in primarily adult psychiatric inpatients.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
Published: January 07, 2026

Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks.

Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 03, 2026

Survival Following a Tricyclic Antidepressant Overdose Presenting With Serotonin Syndrome-Like Symptoms and Critical Illness Polyneuropathy: A Case Report.

Survival Following a Tricyclic Antidepressant Overdose Presenting With Serotonin Syndrome-Like Symptoms and Critical Illness Polyneuropathy: A Case Report.

Journal: Cureus
Published: January 02, 2026

The evolving serotonin syndrome spectrum: from acute syndrome to smoldering presentations and personalized risk management.

The evolving serotonin syndrome spectrum: from acute syndrome to smoldering presentations and personalized risk management.

Journal: Expert opinion on drug metabolism & toxicology
Published: December 24, 2025

Serotonin syndrome risk with concomitant opioid and serotonergic antidepressant use: a multinational pharmacovigilance study.

Serotonin syndrome risk with concomitant opioid and serotonergic antidepressant use: a multinational pharmacovigilance study.

Journal: Frontiers in pharmacology
Published: December 23, 2025

Safety Concerns, Mechanistic Pathways, and Knowledge Gaps in the Clinical Use of Selective Serotonin Reuptake Inhibitors.

Safety Concerns, Mechanistic Pathways, and Knowledge Gaps in the Clinical Use of Selective Serotonin Reuptake Inhibitors.

Journal: Cureus
Published: December 20, 2025

Serotonin Syndrome With Quetiapine, Rizatriptan, Gabapentin, and Propranolol.

Serotonin Syndrome With Quetiapine, Rizatriptan, Gabapentin, and Propranolol.

Journal: The primary care companion for CNS disorders
Published: December 10, 2025

Carisoprodol poisoning with serotonin toxicity.

Carisoprodol poisoning with serotonin toxicity.

Journal: BMJ case reports
Published: December 08, 2025
Showing 1-12 of 2,160

Last Updated: 04/28/2026